BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12889538)

  • 1. Interaction of quinidine, disopyramide and metoprolol with melanin in vitro in relation to drug-induced ocular toxicity.
    Buszman E; Rózańska R
    Pharmazie; 2003 Jul; 58(7):507-11. PubMed ID: 12889538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of thioridazine with ocular melanin in vitro.
    Buszman E; Rózańska R
    Acta Pol Pharm; 2003; 60(4):257-61. PubMed ID: 14714852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of chlorpromazine, fluphenazine and trifluoperazine with ocular and synthetic melanin in vitro.
    Buszman E; Beberok A; Rózańska R; Orzechowska A
    Pharmazie; 2008 May; 63(5):372-6. PubMed ID: 18557422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of neomycin, tobramycin and amikacin with melanin in vitro in relation to aminoglycosides-induced ototoxicity.
    Buszman E; Wrześniok D; Trzcionka J
    Pharmazie; 2007 Mar; 62(3):210-5. PubMed ID: 17416198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanin counter act puromycin-induced inhibition of collagen and DNA biosynthesis in human skin fibroblasts.
    Wrześniok D; Surazyński A; Karna E; Buszman E; Pałka J
    Life Sci; 2005 Jun; 77(5):528-38. PubMed ID: 15904670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanin potentiates kanamycin-induced inhibition of collagen biosynthesis in human skin fibroblasts.
    Wrześniok D; Buszman E; Karna E; Pałka J
    Pharmazie; 2005 Jun; 60(6):439-43. PubMed ID: 15997833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.
    Debing I; Ijzerman AP; Vauquelin G
    Mol Pharmacol; 1988 Apr; 33(4):470-6. PubMed ID: 3357487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation of Ocular Melanin Drug Binding Assays. Alternatives to the Model of Multiple Classes of Independent Sites.
    Manzanares JA; Rimpelä AK; Urtti A
    Mol Pharm; 2016 Apr; 13(4):1251-7. PubMed ID: 26820602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amikacin, kanamycin and tobramycin binding to melanin in the presence of Ca(2+) and Mg(2+) ions.
    Wrześniok D; Buszman E; Miernik-Biela E
    Acta Pol Pharm; 2012; 69(6):1035-41. PubMed ID: 23285663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [UV-Vis spectroscopic study of aluminum-manganese cooperative effect on the melanin formation from DOPA oxidation].
    Di Jun-Wei ; Bi SP
    Guang Pu Xue Yu Guang Pu Fen Xi; 2005 Jan; 25(1):83-5. PubMed ID: 15852826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of the melanin binding of p-bromo-methylamphetamine (V-111).
    Báthory G; Szökö E; Magyar K; Deutsch T
    Pol J Pharmacol Pharm; 1990; 42(1):19-27. PubMed ID: 2281018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the mechanism of chloroquine binding to synthetic DOPA-melanin.
    Stepień KB; Wilczok T
    Biochem Pharmacol; 1982 Nov; 31(21):3359-65. PubMed ID: 6816244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid-chromatographic determination of antidysrhythmic drugs: procainamide, lidocaine, quinidine, disopyramide, and propranolol.
    Kabra PM; Chen SH; Marton LJ
    Ther Drug Monit; 1981; 3(1):91-101. PubMed ID: 7233493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative comparison of the anticholinergic and antiarrhytmic actions of disopyramide and quinidine.
    Pérez A; Ledea N; Hermández K; Garcia-Barreto D
    Pol J Pharmacol Pharm; 1977; 29(5):527-32. PubMed ID: 593967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of drugs to eye melanin is not predictive of ocular toxicity.
    Leblanc B; Jezequel S; Davies T; Hanton G; Taradach C
    Regul Toxicol Pharmacol; 1998 Oct; 28(2):124-32. PubMed ID: 9927562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of flavins with melanin. Studies on equilibrium binding of riboflavin to dopa-melanin and some spectroscopic characteristics of flavin-melanin complex.
    Kozik A; Korytowski W; Sarna T; Bloom AS
    Biophys Chem; 1990 Oct; 38(1-2):39-48. PubMed ID: 2128193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.
    Lima JJ; Boudoulas H; Blanford M
    J Pharmacol Exp Ther; 1981 Dec; 219(3):741-7. PubMed ID: 7299695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of metal ions on netilmicin-melanin interaction.
    Wrześniok D; Buszman E; Grzegorczyk M; Grzegorczyk A; Hryniewicz T
    Acta Pol Pharm; 2012; 69(1):41-5. PubMed ID: 22574505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding affinity of bunazosin, dorzolamide, and timolol to synthetic melanin.
    Kiuchi Y; Terakawa N; Nakata T; Yamasaki K; Saito Y; Ito N; Okada K
    Jpn J Ophthalmol; 2004; 48(1):34-6. PubMed ID: 14767648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of [3H]flunitrazepam binding to melanin.
    Testorf MF; Kronstrand R; Svensson SP; Lundström I; Ahlner J
    Anal Biochem; 2001 Nov; 298(2):259-64. PubMed ID: 11700981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.